Everest Medicines is committed to strengthening its systems and procedures to integrate Environmental, Social and Governance (ESG) as a key consideration into management and operations. Quality remains the top priority in all aspects of Everest Medicines’ business. We continue to place great emphasis on promoting quality management in clinical trials, product development, and the management of third-party vendors.

In terms of business ethics, we value integrity, transparency, honesty and continue to uphold strong ethical standards across our business operations.

Environmental, Social and Governance Reports

                                                                                                                                   
2023 ESG Report                                                            2022 ESG Report                                                             2021 ESG Report

ESG Recognition:

ESCAP Sustainable Business Network (ESBN) Asia-Pacific Green Deal Green Badge

Green Badge acts as a recognition of our pledge of support towards the ESCAP Sustainable Business Network (ESBN) Asia-Pacific Green Deal. ESCAP is the most inclusive intergovernmental platform in the Asia-Pacific region that promotes cooperation among its 53 member States and 9 associate members in pursuit of solutions to sustainable development challenges. Through the badge, we demonstrate our commitment to sustainability to customers, investors, and financiers.